Transforming growth factor β (TGF-β) is abundant in these cancers and has been identified as the main soluble factor in the TME responsible for suppressing IFN-α secretion by TA-pDCs through inhibition of IRF7 signaling (83, 84, 86). Here, IRF7 is linked to cancer.